Ekaterina Dokukina

Ekaterina Dokukina has extensive work experience in the field of clinical trials and healthcare. Ekaterina is currently the Head of Clinical Trials at Eilean Therapeutics and the VP in Clinical Trials at Viriom Inc. Prior to these roles, they served as the Vice President in Clinical Trials at MedInvestgroup. From 2018 to 2021, Ekaterina was the Director at Юнинова мед (UNINOVA). Ekaterina also held various positions at BIOCAD, including Clinical Research Director, R&D Manager, Deputy Clinical Research Department/Project Manager, Project Manager, and CRA I-II. Ekaterina began their career as a Biomedical Science Assistant at Royal Sussex County Hospital and worked as a General Practitioner at Public City Hospital #98 and Saint Petersburg Public Healthcare Polyclinic 98.

Ekaterina Dokukina completed their education at Saint Petersburg State Medical Academy named after I.I. Mechnikov from 2000 to 2006, earning a Doctor of Medicine (MD) degree. Ekaterina later pursued a Master of Philosophy (MPhil) degree in Cardiovascular Science at King's College London from 2010 to 2014.